Menu
The CRISPRIL consortium was established to address the CRISPR-Cas challenges. The CRISPRIL consortium aims to develop an artificial intelligence-based system, “GOGENOME”, providing users with improved genome-editing workflows, and predictable accuracy and efficacy.
Choose your genomic loci for editing:
Genomes, Cell types, Genetic element
Support Cas9, Cas12a , other
Choose your desired type of modification:
Knock-Out, Knock-In, HDR, other
Standardize protocol
Meta data & data
Cloud-based collection platform
Choose your preferred editing Cas system:
Cas9, Cas12a, other
On target & Off target
CRISPRIL 23 participants include leading companies, medical centers, and academic institutions.
The CRISPRIL is supported with research and development grants from the Israel Innovation Authority (IIA). The CRISPRIL consortium operates under the Magnet Consortium track of the IIA
Here are the latest CRISPRIL appearances in the media